KOPP INVESTMENT ADVISORS LLC - Q2 2015 holdings

$225 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 81 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 9.8% .

 Value Shares↓ Weighting
OCLR BuyOclaro, Inc.$24,336,000
+21.7%
10,768,344
+6.7%
10.84%
+22.5%
EMKR BuyEmcore Corp.$19,229,000
+15.5%
3,194,223
+4.4%
8.56%
+16.2%
FNSR BuyFinisar Corp.$17,541,000
-15.9%
981,569
+0.5%
7.81%
-15.3%
SUPN BuySupernus Pharmaceuticals, Inc.$15,124,000
+103.9%
890,705
+45.2%
6.74%
+105.2%
XENT BuyIntersect ENT Inc.$11,961,000
+461.8%
417,788
+406.8%
5.33%
+465.5%
IG BuyIGI Laboratories, Inc.$11,734,000
-5.4%
1,862,475
+22.5%
5.23%
-4.8%
NEO BuyNeoGenomics Inc$10,626,000
+30.7%
1,964,198
+12.8%
4.73%
+31.5%
RTIX BuyRTI Surgical Inc.$10,060,000
+42.3%
1,557,262
+8.8%
4.48%
+43.2%
GIMO BuyGigamon Inc.$9,815,000
+512.3%
297,530
+294.2%
4.37%
+516.5%
IL BuyIntraLinks Holdings Inc.$7,180,000
+356.7%
602,840
+296.6%
3.20%
+359.5%
ATRC BuyAtriCure Inc.$5,017,000
+21.1%
203,620
+0.7%
2.23%
+21.9%
AKRXQ BuyAkorn, Inc.$4,067,000
-7.8%
93,153
+0.3%
1.81%
-7.3%
CTCT BuyConstant Contact, Inc.$3,263,000
+52.1%
113,473
+102.0%
1.45%
+52.9%
GPRO NewGoPro Inc.cl a$3,240,00061,460
+100.0%
1.44%
CEMP BuyCempra, Inc$3,103,000
+647.7%
90,312
+647.3%
1.38%
+651.1%
LGND BuyLigand Pharmaceuticals Inc$2,809,000
+48.7%
27,844
+13.6%
1.25%
+49.6%
ARRY BuyArray Biopharma Inc.$2,762,000
-1.7%
383,022
+0.5%
1.23%
-1.0%
SCON BuySuperconductor Technologies, Inc.$2,695,000
-16.6%
2,566,277
+12.0%
1.20%
-16.1%
ENZ BuyEnzo Biochem, Inc$2,492,000
+29.7%
822,522
+26.3%
1.11%
+30.4%
ANGO BuyAngiodynamics, Inc.$2,328,000
-7.5%
141,923
+0.3%
1.04%
-6.9%
FLDM BuyFluidigm Corp.$1,943,000
-11.5%
80,288
+54.0%
0.86%
-10.9%
NXTM BuyNxStage Medical, Inc$1,669,000
+390.9%
116,850
+494.7%
0.74%
+395.3%
WFC BuyWells Fargo & Co.$1,147,000
+4.1%
20,399
+0.7%
0.51%
+4.7%
EMN BuyEastman Chemical Co.$1,022,000
+40.2%
12,496
+18.7%
0.46%
+40.9%
HRL BuyHormel Foods Corporation$1,006,000
+0.9%
17,855
+1.8%
0.45%
+1.6%
JWN BuyNordstrom Inc.$964,000
-1.5%
12,940
+6.2%
0.43%
-0.9%
AFL BuyAflac Incorporated$912,000
+2.6%
14,659
+5.5%
0.41%
+3.3%
AXP BuyAmerican Express Company$899,000
+4.4%
11,571
+5.0%
0.40%
+5.0%
TROW BuyT. Rowe Price$881,000
-3.2%
11,330
+0.8%
0.39%
-2.7%
MXL BuyMaxLinear, Inc.cl a$871,000
+51.5%
71,949
+1.7%
0.39%
+52.8%
JNJ BuyJohnson & Johnson$869,000
-2.2%
8,913
+0.8%
0.39%
-1.5%
PG BuyThe Procter & Gamble Company$869,000
-3.8%
11,112
+0.8%
0.39%
-3.2%
VZ BuyVerizon Communications, Inc.$848,000
-3.9%
18,191
+0.3%
0.38%
-3.1%
NOV BuyNational Oilwell Varco Inc.$734,000
+13.4%
15,205
+17.5%
0.33%
+14.3%
XOM BuyExxon Mobil Corporation$705,000
-1.0%
8,470
+1.1%
0.31%
-0.3%
CVLT BuyCommVault Systems Inc.$584,000
-2.8%
13,761
+0.1%
0.26%
-2.3%
FLML BuyFlamel Technologies SA Spons Asponsored adr$496,000
+56.5%
23,419
+32.8%
0.22%
+57.9%
VCYT BuyVeracyte Inc.$435,000
+62.3%
39,085
+6.2%
0.19%
+63.0%
SIEN NewSientra, Inc.$268,00010,615
+100.0%
0.12%
AERI BuyAerie Pharmaceuticals, Inc.$240,000
-7.3%
13,590
+64.5%
0.11%
-7.0%
AAPL BuyApple Inc.$236,000
+12.9%
1,880
+11.9%
0.10%
+14.1%
CLDX BuyCelldex Therapeutics Inc.$219,000
-5.2%
8,692
+4.9%
0.10%
-3.9%
BLUE NewBluebird Bio. Inc$212,0001,261
+100.0%
0.09%
HWAY NewHealthways Inc.$180,00015,040
+100.0%
0.08%
NVDQ BuyNovadaq Technologies Inc.$150,000
-21.5%
12,417
+5.8%
0.07%
-21.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-08-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NeoGenomics Inc.26Q3 20198.2%
RTI Surgical Inc.26Q3 20196.0%
Omnicell Inc.26Q3 20194.7%
AtriCure Inc.26Q3 20194.6%
Ligand Pharmaceuticals Inc.26Q3 20194.5%
SPDR Trust Ser 126Q3 20192.3%
Marriott Intl. Inc.26Q3 20191.5%
Southwest Airls Co.26Q3 20191.3%
3M Company26Q3 20191.2%
Aflac Incorporated26Q3 20191.1%

View KOPP INVESTMENT ADVISORS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
KOPP INVESTMENT ADVISORS LLC Q2 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SUPERCONDUCTOR TECHNOLOGIES INCAugust 19, 2016528,96316.6%
EMCORE CORPApril 01, 20161,248,9704.8%
VITESSE SEMICONDUCTOR CORPMay 05, 2015? ?
TRANSGENOMIC INCMay 23, 201483,5021.1%
RTI SURGICAL, INC.January 03, 20141,984,6183.5%
SYNERGETICS USA INCJanuary 03, 2014877,2533.5%
MINDSPEED TECHNOLOGIES, INCDecember 13, 20132,068,4164.8%
TRANSGENOMIC INCNovember 01, 201313,744,08615.6%
OCLARO, INC.September 20, 20138,592,5179.3%
SUPERCONDUCTOR TECHNOLOGIES INCDecember 21, 20128,776,33517.4%

View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR/A2018-08-15
13F-HR2018-08-14
13F-HR2018-05-14
13F-HR2018-02-14
13F-HR2017-11-14

View KOPP INVESTMENT ADVISORS LLC's complete filings history.

Compare quarters

Export KOPP INVESTMENT ADVISORS LLC's holdings